Literature DB >> 17019604

Variants in the 5' region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects.

S S Torekov1, L H Larsen, G Andersen, A Albrechtsen, C Glümer, K Borch-Johnsen, T Jørgensen, T Hansen, O Pedersen.   

Abstract

AIMS/HYPOTHESIS: The gene encoding neuropeptide Y receptor Y2 (NPY2R) is widely expressed in the central nervous system, with particularly high abundance in the hypothalamus, which is known to be important for appetite regulation. We tested whether variations in NPY2R are associated with obesity.
METHODS: The coding region of NPY2R was analysed for mutations in 48 obese Danish white subjects and two silent substitutions were identified: SNPs 1 and 2 (rs1047214 and rs2880415). SNP1 and additional reported variants (SNPs 3-6 [rs11099992, rs12649641, rs2342676 and rs6857530]) located in the 5' region were examined in 5,971 Danish white subjects. Since SNPs 1-2 and 4-6, respectively, were in tight linkage disequilibrium large-scale analyses of genetic epidemiology were restricted to SNPs 1, 3 and 4.
RESULTS: Homozygous carriers of the minor A allele of SNP4 were more common among obese subjects; the AA frequency was 15.9 (95% CI 15.2-16.6) among 4,837 non-obese subjects (BMI <30 kg/m(2)) vs 19.0 (95% CI 17.2-20.8) among 960 obese subjects (BMI > or =30 kg/m(2)), odds ratio 1.24 (95% CI 1.04-1.48), p=0.02. SNPs 1-3 were not associated with obesity. CONCLUSIONS/
INTERPRETATION: Common variants rs12649641, rs2342676 and rs6857530 in the 5' region of NPY2R are associated with obesity in Danish white subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019604     DOI: 10.1007/s00125-006-0425-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

Authors:  Torben Jørgensen; Knut Borch-Johnsen; Troels F Thomsen; Hans Ibsen; Charlotte Glümer; Charlotta Pisinger
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2003-10

2.  Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor.

Authors:  P Naveilhan; H Hassani; J M Canals; A J Ekstrand; A Larefalk; V Chhajlani; E Arenas; K Gedda; L Svensson; P Thoren; P Ernfors
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

3.  Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.

Authors:  C Broberger; M Landry; H Wong; J N Walsh; T Hökfelt
Journal:  Neuroendocrinology       Date:  1997-12       Impact factor: 4.914

4.  Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes.

Authors:  Signe S Torekov; Lesli H Larsen; Charlotte Glümer; Knut Borch-Johnsen; Torben Jørgensen; Jens J Holst; Ole D Madsen; Torben Hansen; Oluf Pedersen
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

5.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

6.  Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits.

Authors:  Chiao-Chien Connie Hung; Fraser Pirie; Jian'an Luan; Emma Lank; Ayesha Motala; Giles S H Yeo; Julia M Keogh; Nicholas J Wareham; Stephen O'Rahilly; I Sadaf Farooqi
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36.

Authors:  D Grandt; M Schimiczek; C Beglinger; P Layer; H Goebell; V E Eysselein; J R Reeve
Journal:  Regul Pept       Date:  1994-05-05

9.  Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.

Authors:  Sudhakar Misra; Karnam S Murthy; Huiping Zhou; John R Grider
Journal:  J Pharmacol Exp Ther       Date:  2004-08-12       Impact factor: 4.030

10.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

View more
  10 in total

1.  Candidate molecular pathway genes related to appetite regulatory neural network, adipocyte homeostasis and obesity: results from the CARDIA Study.

Authors:  Yechiel Friedlander; Guo Li; Myriam Fornage; O Dale Williams; Cora E Lewis; Pamela Schreiner; Mark J Pletcher; Daniel Enquobahrie; Michelle Williams; David S Siscovick
Journal:  Ann Hum Genet       Date:  2010-07-14       Impact factor: 1.670

Review 2.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

3.  Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects.

Authors:  Steven C Hunt; Sandra J Hasstedt; Yuanpei Xin; Brian K Dalley; Brett A Milash; Emanuel Yakobson; Richard E Gress; Lance E Davidson; Ted D Adams
Journal:  Obesity (Silver Spring)       Date:  2011-08-04       Impact factor: 5.002

Review 4.  Recent progress in the genetics of common obesity.

Authors:  Ruth J F Loos
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

5.  Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs.

Authors:  Zhiyun Wei; Kuixing Zhang; Gen Wen; Karthika Balasubramanian; Pei-an B Shih; Fangwen Rao; Ryan S Friese; Jose P Miramontes-Gonzalez; Geert W Schmid-Schoenbein; Hyung-Suk Kim; Sushil K Mahata; Daniel T O'Connor
Journal:  J Hypertens       Date:  2013-01       Impact factor: 4.844

6.  Changes in white adipose tissue gene expression in a randomized control trial of dieting obese men with lowered serum testosterone alone or in combination with testosterone treatment.

Authors:  Mathis Grossmann; Mark Ng Tang Fui; Tian Nie; Rudolf Hoermann; Michele V Clarke; Ada S Cheung; Jeffrey D Zajac; Rachel A Davey
Journal:  Endocrine       Date:  2021-04-17       Impact factor: 3.633

7.  Peripherally Administered Y2-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice.

Authors:  Liisa Ailanen; Laura H Vähätalo; Henriikka Salomäki-Myftari; Satu Mäkelä; Wendy Orpana; Suvi T Ruohonen; Eriika Savontaus
Journal:  Front Pharmacol       Date:  2018-04-05       Impact factor: 5.810

8.  Association between gene polymorphisms and obesity and physical fitness in Korean children.

Authors:  Hyun Jun Kim; Sang Yeoup Lee; Cheol Min Kim
Journal:  Biol Sport       Date:  2017-10-12       Impact factor: 2.806

9.  Integrating human omics data to prioritize candidate genes.

Authors:  Yong Chen; Xuebing Wu; Rui Jiang
Journal:  BMC Med Genomics       Date:  2013-12-18       Impact factor: 3.063

10.  Candidate genes for predicting the survival of patients with gastric cancer: a study based on The Cancer Genome Atlas (TCGA) database.

Authors:  Xiqiao Liu; Liying Gao; Dongqiong Ni; Chengao Ma; Yuping Lu; Xuan Huang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.